Available Grant Opportunities

 

Week of July 2nd-8th, 2018

Check back often for weekly updates

 

INTERNAL GRANT OPPORTUNITIES

Internal Funding Opportunities & Limited Submission Grants:

 

A. Alfred Taubman Medical Research Institute – Innovation Programs: Phenotyping in the Clinical Setting (Award amount variable, rolling deadline).  

http://www.taubmaninstitute.org/science/taubman-institute-innovation-program/ 

The Taubman Institute is seeking to support new or existing teams of scientists to develop novel and impactful approaches to integrate their research programs into the clinic setting. The goal is to perform systematic, multiscale phenotyping to gain insights into individual variation in the susceptibility, progression, course, or outcomes of disease. The institute will partner with investigators to support the development and implementation of their research programs. This will include, but not be limited to, development of a research plan, identification of research partners within and external to U-M, infrastructure and database development, support for clinician and ancillary personnel in the clinic, clinical data collection, biological specimen collection, remote data collection, initiation of research plan, and data analysis. Our goal is to make every patient a research subject, and to define the genetic, environmental, behavioral and other components of individuals that contribute to their distinct emergent property related to health and disease. The goal is to also utilize the data to stratified an individual in order apply interventions that lead to the prevention, improved treatment, or cure of disease. The institute anticipates investing up to $2.5 million per year to support the funded projects. What are the criteria for funding? Impact on improving the lives of patients; Innovation in understanding the variability in onset or progression of disease, and reasons for differential response to treatment; Potential for future funding by the NIH or other external agencies; Potential for increased reimbursement for care by insurance companies, or cost savings to the medical system; and, Enhanced interactions with basic or other science disciplines (teams). Letter of intent:  Description of the proposed program. Who is going to work together and what will be their roles? Have you worked together in the past? Where do you want to perform this work? What infrastructure is needed to accomplish the goals? Who will you need to partner with to succeed? What are the present barriers to your success? What are your plans for downstream funding? Note: not all of these points must be addressed in the LOI. We seek to understand your vision for bringing science into the clinic. The main request here is for an outline of what you want to do and why it will be impactful. There is no deadline. Letters of intent are accepted on a rolling basis, and should be submitted to managing director Grace Wu (glwu@umich.edu). We encourage questions. You may contact us with written questions through Grace Wu (glwu@umich.edu). We’re happy to meet with individuals or teams to discuss ideas.

 

Michigan Center for Therapeutic Innovation and Fast Forward Medical Innovation 2018 Request for Proposal for the U-M Therapeutic Innovation Fund ($150,000 award, deadline July 13th, 2018).  https://umms.infoready4.com/#competitionDetail/1772724  The Michigan Center for Therapeutic Innovation and Fast Forward Medical Innovation (FFMI) are happy to announce the 2018 RFP for the U-M Therapeutic Innovation Fund. The U-M Therapeutic Innovation Fund RFP: The Michigan Center for Therapeutic Innovation (MCTI) and Fast Forward Medical Innovation (FFMI) offer a five-year, $2.5 million fund created to accelerate the discovery and translation of therapeutic candidates at the University of Michigan. The fund supports the discovery and optimization of small molecule lead compounds for projects with a specific, novel, and testable drug discovery hypothesis. Selected projects receive funding and resources to support medicinal chemistry efforts through MCTI and funding for drug design, assay development, cell biology, structural biology, and pharmacology (up to $150,000 in value for each award for up to 18 months). A pre-submission application and meeting must be completed on or before Friday, July 13, 2018. The submission deadline for the full proposal will be on Friday, July 27, 2018 at 5pm. Please contact Jason Rech at jcrech@umich.edu or Visha Krishnan at kvisha@umich.edu if you have any questions about the funding opportunity or would like to schedule a pre-submission meeting.

 

2019 Searle Scholars Program ($300,000 award, internal competition deadline July 23rd, 2018).  https://umms.infoready4.com/?mc_cid=90620d8481&mc_eid=658fd7e061#competitionDetail/1772720

Nominations of faculty from all units of the University are welcome. Program Focus: The Searle Scholars Program gives grants to support independent research in medicine, chemistry, and the biological sciences for exceptional early-career scientists who have recently begun their appointment at the assistant professor level, and whose appointment is their first tenure-track position. More information on the Searle Scholars Program website:  http://www.searlescholars.net/  The University may submit two candidates to apply for the 2019 Searle Scholars Program. The Searle Scholars Program online application submission system will be available to selected individuals once nominations have been placed. The final application submission deadline is Friday, September 28, 2018 (5:00 PM CDT). Funding Available: $300,000 ($100,000 per year for a three year period). Questions: Please contact Paula Van Velden (734) 615-8802, paulavan@umich.edu or Laura Hessler (734) 615-6575, lauralh@umich.edu. Searle Scholars Program Information Session: Thursday, June 28, 2018, 2:00 PM - 3:00 PM, Taubman Library room #5000.  Maureen Martin, Executive Director for Foundation Relations and Joseph Piffaretti, Senior Director for Corporate and Foundation Relations will conduct an information session on the Searle Scholars Program covering: Overview of the Searle Scholar Program; The Application Process; Writing the Proposals; Common Strengths and Weaknesses; and, Q&A.  Please RSVP for the Information Session. 2019 Searle Scholars Program Internal Deadline: Monday, July 23, 2018 (11:59 PM EDT).

 

Rita Allen Foundation – Scholars Program 2019 ($550,000 award, internal limited submission deadline August 1st, 2018 by 5:00 PM). https://umms.infoready4.com/?mc_cid=1a44a34e4b&mc_eid=658fd7e061#competitionDetail/1774053  The Rita Allen Foundation Scholars program has a rich history of investing in young leaders and their research aimed to advance transformative ideas at their earliest stages and leverage them to promote breakthrough solutions. They have sought research projects with above-average risk that break new ground and challenge the status quo. Discipline/Subject Area: Research leading to breakthrough solutions in the cure and treatment of diseases in the fields of cancer, immunology and neuroscience. Internal Deadline: Wednesday, August 1, 2018 (by 5:00 PM).  Please contact Paula Van Velden, paulavan@umich.edu, (734) 615-6575, with any questions.

 

Michigan Health Endowment Fund – Healthy Aging and Caregiving Program ($500,000 award, deadline August 2nd – but please see notes below for U-M internal deadlines and feedback opportunities).  https://mhef.fluxx.io/user_sessions/new  Amount: Up to $500K over 1-2 years.  Deadlines: July 13, 2018 (5 PM) Concept Papers due (recommended; if you want feedback). August 2, 2018 (5 PM) Applications due. July 16, 2018 (5 PM) Project abstracts for institutional leadership letters signed by President Schlissel due to Donna Lartigue. Interest Areas: Healthy Aging: Improving access and availability of integrated, comprehensive services delivered in a person-centered way for older adults in Michigan. Innovation – develop and pilot new models involving nontraditional partners. Access – improving access to current or expanded service array through technology advancements, integration of services, increased workforce availability or other strategies. Systems – address structural barriers and inefficiencies that prevent systems from delivering care to patients. Issues – address a significant issue or health disparity that impacts older adults. Caregiving: New focus area; goal is to increase support for formal and informal caregivers, especially those working with low- to moderate-income community-dwelling older adults. Projects around caregiving should address information and assistance, assessments, and home-based or community service delivery.

The Ralph C. Wilson Jr. Foundation provided $1 million in additional funding for caregiving focused on Southeast Michigan (Washtenaw, Monroe, Wayne, Livingston, Oakland, Macomb and St. Clair counties). Applicants must directly address at least one of the Health Fund's two cross-cutting goals: Build, extend and strengthen workforce capacity through training and development for clinicians, program staff, and informal caregivers. Develop and expand innovative and cost-effective integration models that coordinate care, services, and resources to promote the health of older adults in Michigan. If you wish to include a letter from the President, send an abstract of your project to Donna Lartigue lartigue@umich.edu (U-M Work 734-647-0282) by July 16, 2018. Evidence suggests that a letter from your dean or director is sufficient, however.

 

 

EXTERNAL GRANT OPPORTUNITIES

 

Robert Wood Johnson Foundation – Evaluating the Four-Day School Week Policy 2018 – Call for Proposals ($1 million award, brief proposal deadline July 30th, 2018 – note – optional July 9th applicant webinar).   https://www.rwjf.org/en/library/funding-opportunities/2018/evaluating-the-four-day-school-week-policy.html?rid=0034400001rm28IAAQ&et_cid=1288378  This Robert Wood Johnson Foundation (RWJF) funding opportunity will provide up to $1 million to support an evaluation of a four-day school week policy in rural settings and an associated cost study. The goal of this award is to build the field’s evidence about the pros and cons of this policy and its impact on children’s academic, social, emotional, and physical well-being, as well as the potential impacts on their families and broader communities. This research is intended to guide policy decisions of educators in rural communities in ways that promote the health and well-being of the whole child. One research grant of up to $1 million will be awarded through this call for proposals (CFP). July 9, 2018 (1 p.m. ET): Optional applicant webinar.  July 30, 2018 (3 p.m. ET): Deadline for receipt of brief proposals.

 

American Cancer Society  

  • Clinician Scientist Development Grants ($675,000 award + 8% IDC’s, deadline October 15th, 2018). https://proposalcentral.altum.com/GrantOpportunities.asp?GMID=11 With a primary focus on beginning investigators, the American Cancer Society’s Extramural Research Program seeks to support innovative cancer research across a wide range of disciplines to meet critically important needs in the control of cancer. Clinician Scientist Development Grant— Fosters the development of clinicians as clinician scientists. Clinician scientists are investigators licensed to provide patient care and trained to conduct research. They pursue research questions across the cancer research continuum of relevance to improving health. CSDGs provides support for protected time to allow junior faculty who see patients to be mentored and participate in research training to aid their development as independent clinician scientists. Applicants must be full-time and within the first six years of their initial faculty appointment. Awards range from three to five years and for up to $135,000 per year (direct costs), plus 8% allowable indirect costs. A maximum of $10,000 per year for the mentor(s) (regardless of the number of mentors) is included in the $135,000. Electronic Application Deadline: October 15, 2018.

 

  • Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families ($120,000 award + 20% IDC’s, deadline October 15th, 2018). https://proposalcentral.altum.com/GrantOpportunities.asp?GMID=11 Pilot and Exploratory Projects in Palliative Care of Cancer Patients and their Families — Supports investigators performing pilot and exploratory research studies that test interventions, develop research methodologies, and explore novel areas of research in palliative care of cancer patients and their families. Applications will be accepted via the Pilot and Exploratory Grants Mechanism. The maximum award is for 2 years and up to $60,000 per year (direct costs) plus 20% indirect costs. Electronic Application Deadline: October 15, 2018. Paper Application Copy Deadline: October 16, 2018.

 

Susan G. Komen – Career Catalyst Research Grants Conquering Metastatic Breast Cancer 2018-2019 Letter of Intent ($450,000 award, Letter of Intent deadline August 1st, 2018).  https://ww5.komen.org/ResearchGrants/FundingOpportunities.html  Susan G. Komen is requesting Letters of Intent for the FY19 CCR Grant program that propose outstanding translational research into the understanding, detection, and treatment of metastatic breast cancer which will lead to a reduction in breast cancer deaths by 2026.  Appropriate studies for this mechanism include, but are not limited to: Development of novel treatment strategies for existing metastatic disease. This could include applications that address drug resistance, research that investigates approaches to improve delivery of existing therapies to metastatic disease, as well as studies focused on the immune system and potential vaccine strategies; New approaches to detect recurrence and strategies to prevent or arrest metastasis. This could include studies that focus on the mechanisms of metastatic growth. Correlative studies of existing clinical trials for metastatic breast cancer, including analysis of biopsies and other patient samples. Such studies should leverage existing clinical trials to advance the understanding and treatment of metastatic breast cancer, including early recurrence; Investigating disparities leading to a higher burden of metastatic disease in certain populations, including biological or social causes, and/or interventions that eliminate disparities in metastatic breast cancer patients; and, Utilizing data science methods to better understand and treat metastatic breast cancer.  Applications that fit the focus area as detailed above and include studies that address metastatic breast cancer disparities, or leverage data science to better understand and treat metastatic breast cancer are highly encouraged. For these purposes, metastatic breast cancer disparities research is defined as research investigating the biologic, behavioral, social and systems contributors to late-stage (metastatic) breast cancer in population groups affected by breast cancer disparities. This may include the identification, validation and testing of biological and/or socioeconomic factors that contribute to breast cancer disparities in metastatic breast cancer. This may also include identification of health services and public health interventions that address the causes of disparities in care and outcomes across population groups in metastatic breast cancer. Data science includes artificial intelligence and other analytical methods applied to data aggregated from multiple sources (Electronic Health Records, other clinical data, administrative databases, large data repositories, genomics and other -omics data, etc.). Basic science studies focused on the mechanisms of breast cancer cell motility and broad exploratory (i.e. “hypothesis generating”) studies are NOT appropriate for this Grant mechanism. Letters of Intent addressing topics other than the focus area, as described above, will be administratively withdrawn from consideration without an opportunity for appeal. Applicants/PIs may only submit ONE LOI per funding cycle.  Applicants/PIs may request funding of up to $150,000 per year (combined direct and indirect costs) for up to three years ($450,000). Letter of Intent Due: August 1, 2018, by 1 p.m., Eastern Standard Time.

 

American Association for the Study of Liver Diseases

  • Pinnacle Research Award in Liver Disease ($300,000 award, deadline December 4th, 2018).  https://www.aasld.org/research-awards/research-career-development-awards/pinnacle-research-award-liver-disease The Pinnacle Research Award in Liver Disease is a three-year basic science award that provides young scientists with support for their research to bridge the gap between completion of research training and attainment of status as an independent research scientist. The additional research experience provided by this award is intended to enable young scientists to successfully compete for research awards from national sources, particularly the National Institutes of Health (NIH). Well-trained investigators who hold MD, PhD or MD/PhD degrees and are pursuing a career in liver disease research are encouraged to apply. The Pinnacle Research Award is intended to develop the potential of outstanding, young scientists and encourage research in liver physiology and disease. Individuals who are already well-established in the field are not eligible for this award. Applications in this category may be eligible for special funding from the Autoimmune Hepatitis Research Fund. Applicant may only apply for one (1) AASLD Foundation (AASLDF) award per application cycle. The award of $300,000 will be provided over three years ($100,000 per year). The application deadline for this award is 11:59 pm ET, December 4, 2018.

 

  • Clinical, Translational, and Outcomes Research Awards ($200,000 award, deadline December 4th, 2018).  https://www.aasld.org/research-awards/research-career-development-awards/clinical-translational-and-outcomes-research-award The Clinical, Translational and Outcomes Research Awards in Liver Diseases are two-year awards of $200,000 ($100,000/year) intended to foster career development for individuals performing clinical research, translational research, or outcomes research in a liver-related area and who have shown commitment to excellence at an early stage of their research study. The awards ensure that a significant portion of young investigator's time is protected for research, with an overall objective of enabling young investigators to develop independent and productive research careers in liver disease. Up to two applications per distinct department will now be accepted per single sponsoring institution.  One award per year will be reserved for meritorious transplant related research in memory of the University of Michigan Transplant Team.  Awards of $200,000 will be provided over two years ($100,000 per year). The application deadline for this award is 11:59 pm ET, December 4, 2018.

 

  • Bridge Award ($100,000 award, two funding cycle deadlines: October 5th, 2018 and January 15th, 2019).  https://www.aasld.org/research-awards/research-career-development-awards/bridge-award The AASLD Foundation Bridge Award supports investigators who have recently submitted an NIH R or other federally-funded equivalent award and have received competitive scores on their proposal, but were not funded, as they strengthen their proposal for resubmission to the NIH or other federal agency. Applicant must not have other federal funding or significant institutional bridge funding (greater than $25,000, excluding PI salary support). Applicant may only apply for one (1) AASLD Foundation (AASLDF) award per application cycle. Awards of $100,000 will be provided over one year. The application deadline for this award is 11:59 pm ET, October 5, 2018 (Cycle I) or 11:59 pm ET, January 15, 2019 (Cycle II).

 

  • Afdhal/McHutchison LIFER Award – Postdoctoral Fellowship ($100,000 award, deadline December 4th, 2018). https://www.aasld.org/research-awards/research-career-development-awards/afdhal-mchutchison-lifer-award  Award Type: Clinical and/or translational research fellowship. The purpose of this two-year, $100,000 ($50,000/year) award is to foster career development for fellows performing clinical research and/or translational research in a liver-related area and who have shown commitment to excellence at an early stage of their research study. The award is intended to ensure that a significant portion of the investigators’ time is protected for research, with an overall objective of enabling the investigators to develop independent and productive research careers in liver disease. International applicants who have been accepted into a fellowship position at a North American institution are strongly encouraged to apply. Applicant may only apply for one (1) AASLD Foundation (AASLDF) award per application cycleOne award of $100,000 will be provided over two years ($50,000 per year.) The application deadline for this fellowship is 11:59 pm ET, December 4, 2018.

 

  • NP/PA Clinical Hepatology Fellowship ($78,000 award, deadline December 4th, 2018).  https://www.aasld.org/research-awards/research-career-development-awards/nppa-clinical-hepatology-fellowship The NP/PA Clinical Hepatology Fellowship provides salary and benefit support for certified and licensed Nurse Practitioners (NP) or Physician Assistants (PA) pursuing a full-year of training focused on clinical care in hepatology and is designed to: Increase the number of associate practitioners in clinical hepatology. Facilitate the transition (or shift in emphasis) into clinical hepatology for associate practitioners. Increase access for liver disease patients to adequately trained clinicians. Only one application per institution will be accepted for consideration. An award of $78,000 will be provided for one year. The application deadline for this award is 11:59 pm ET, December 4, 2018.

 

Ho-Am Prize ($275,000 award, deadline October 31st, 2018).  http://hoamprize.samsungfoundation.org/eng/foundation/intro.asp The Ho-Am Prize was established in 1990 by Kun-Hee Lee, the Chairman of Samsung, with a vision to create a new corporate culture that continues the noble spirit of public service espoused by the late Chairman Byung-chull Lee, founder of Samsung. The Prize, named after the late Chairman's pen name, is presented each year to individuals who have contributed to academics, the arts, and social development, or who have furthered the welfare of humanity through distinguished accomplishments in their respective professional fields. Medicine: The Prize for Medicine includes the clinical and research areas of medicine, physiology, and pharmacology. The Prize is awarded to people of Korean heritage who have made distinctive contributions to the efforts of humankind to conquer the disease. Science: The Ho-Am Prize for Science includes such fields as physics, biology, mathematics, astronomy, and other basic sciences. The Prize is presented to people of Korean heritage whose outstanding accomplishments have contributed to the progress of these fields. Recipients of the Ho-Am Prize are each presented with Diploma, a pure gold medal (187.5g) and a cash prize of KRW 300million (approx. 275,000 USD). Nomination Deadline: October 31, 2018.

 

Elsa U. Pardee Foundation – Grants Program (Typical range $120,000 - $200,000 award with 15% IDC’s, funding cycle deadlines of August 31st, 2018 & December 31st, 2018).  http://www.pardeefoundation.org/grants.aspx  The Elsa U. Pardee Foundation funds research to investigators in United States non-profit institutions proposing research directed toward identifying new treatments or cures for cancer. The Foundation particularly encourages grant applications for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified.  By design, there are no limits set on the grant amount that can be requested. It must be reasonably and clearly supported by the scope of the project outlined in the application. Applications requesting more than 15% overhead are usually not considered.

 

Lung Cancer Foundation of America – Lori Monroe Scholarship in Translational Lung Cancer Research 2018 - $200,000 award, deadline August 1st, 2018).  https://lcfamerica.org/research-grants/opportunities/ Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer Foundation (IASLCF) seek applications for the Lori Monroe Scholarship in Lung Cancer Research Awards. Applications addressing the following research areas will be given priority: 1) Facilitating the collaboration, information-sharing and interaction between basic researchers and clinical investigators with the goal of expediting and translating results of scientific investigation into clinical practice to reduce the burden of lung cancer; or 2) Exploring innovative models of lung cancer care delivery; or 3) Exploring the etiologies of lung cancer in the never smoker population. Objectives: The objective of this award is to support research that improves the care of individuals with lung cancers and to reduce the burden of these diseases.  Examples include studies: (1) designed to define the molecular bases of lung cancer risk assessment; (2) to improve molecular diagnostic studies designed to detect the lung cancer early and guide curative-intent therapy; (3) predictive features guiding the use of targeted or immune oncology therapy to reduce recurrence after standard curative-intent strategies in early stage disease; (4) or to improve the outcomes or cure patients with metastatic lung cancer. Studies designed to facilitate care by minimizing treatment side effects or illuminating the causes of nonsmoking related lung cancer are encouraged, as well. Successful applications for this Request for Applications (RFA) announcement require a research approach that seeks to make an immediate and relevant impact on lung cancer patient care or interpret the results of a clinical trial from a molecular basis as appropriate to help inform decisions in future clinical trials. The maximum funding for the award will be in the amount of $200,000. The award amount will be $100,000 per year for up to two years.

Applications are due via the IASLCF’s online portal: https://www.iaslc.org/fellowship/announcements by close of business August 1, 2018 MDT.

 

Harry J. Lloyd Charitable Trust – Melanoma Research Grants ($125,000 award, deadline November 1st, 2018).  https://hjltrust.com/grants/

Grants are awarded in one of three areas: Career Development: May include salary support for promising young melanoma investigators. Basic Science: To gain new biological insights in to melanoma development or progression. Translational Research: To fund clinically important melanoma research. With a special focus on screening and prevention, most individual grants do not exceed $125,000 per year. Each institution is eligible for a maximum of three grants, one in each of the three categories. Applications received after 11:59 p.m. (Central Standard Time) November 1, 2018 will not be considered.